- Home
- VNDA vs STIM Comparison
VNDA vs STIM Comparison
Compare VNDA & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- STIM
- Stock Information
- Founded
- VNDA 2002
- STIM 2003
- Country
- VNDA United States
- STIM United States
- Employees
- VNDA N/A
- STIM N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- VNDA Health Care
- STIM Health Care
- Exchange
- VNDA Nasdaq
- STIM Nasdaq
- Market Cap
- VNDA 237.9M
- STIM 232.3M
- IPO Year
- VNDA 2006
- STIM 2018
- Fundamental
- Price
- VNDA $3.95
- STIM $4.43
- Analyst Decision
- VNDA Strong Buy
- STIM Buy
- Analyst Count
- VNDA 2
- STIM 4
- Target Price
- VNDA $16.50
- STIM $6.00
- AVG Volume (30 Days)
- VNDA 471.1K
- STIM 792.7K
- Earning Date
- VNDA 05-07-2025
- STIM 05-06-2025
- Dividend Yield
- VNDA N/A
- STIM N/A
- EPS Growth
- VNDA N/A
- STIM N/A
- EPS
- VNDA N/A
- STIM N/A
- Revenue
- VNDA $201,351,000.00
- STIM $89,448,000.00
- Revenue This Year
- VNDA $14.36
- STIM $102.36
- Revenue Next Year
- VNDA $44.53
- STIM $9.83
- P/E Ratio
- VNDA N/A
- STIM N/A
- Revenue Growth
- VNDA 13.37
- STIM 22.16
- 52 Week Low
- VNDA $3.85
- STIM $0.52
- 52 Week High
- VNDA $6.75
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- VNDA 33.16
- STIM 54.83
- Support Level
- VNDA $4.20
- STIM $3.30
- Resistance Level
- VNDA $4.51
- STIM $4.82
- Average True Range (ATR)
- VNDA 0.18
- STIM 0.32
- MACD
- VNDA -0.02
- STIM 0.03
- Stochastic Oscillator
- VNDA 1.43
- STIM 74.59
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.